Geographic information |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Geographic information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Geographic information |
Note 13 — Geographic information
Operations by geographic area
Revenue represents recognized income from the GSK Collaboration and License Agreement. All revenue was derived in the United Kingdom.
Long-lived assets (excluding intangibles and financial instruments) were located as follows (in thousands):
Major customers:
During the year ended December 31, 2017 and 2016, six months ended December 31, 2015 and the year ended June 30, 2015 100% of revenues were generated from one customer, which was GSK.
|